Answers are grounded in this paper and cite their sources.
To the Editor According to the study protocol, the recently published study by Aaronson et al1 was carried out "to assess effectiveness of 25 mg of psilocybin in [15] patients with treatment-resistant type 2 bipolar depression." We see 3 concerns.
No takes yet. Share an insight, caveat, or question.
Fried et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: